Avoro Capital Advisors LLC 13D and 13G filings for Amicus Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-05-15 09:30 am Sale | 2025-03-31 | 13G | Amicus Therapeutics, Inc. FOLD | Avoro Capital Advisors LLC | 20,500,000 6.700% | -2,675,000 (-11.54%) | Filing |
| 2024-11-14 09:31 am Sale | 2024-09-30 | 13G | Amicus Therapeutics, Inc. FOLD | Avoro Capital Advisors LLC | 23,175,000 7.800% | -4,225,000 (-15.42%) | Filing |
| 2024-02-14 09:22 am Purchase | 2023-12-31 | 13G | Amicus Therapeutics, Inc. FOLD | Avoro Capital Advisors LLC | 27,400,000 9.300% | 600,000 (+2.24%) | Filing |
| 2023-02-14 09:35 am Purchase | 2022-12-31 | 13G | Amicus Therapeutics, Inc. FOLD | Avoro Capital Advisors LLC | 26,800,000 9.500% | 8,300,000 (+44.86%) | Filing |
| 2022-02-11 10:05 am Purchase | 2021-12-31 | 13G | Amicus Therapeutics, Inc. FOLD | Avoro Capital Advisors LLC | 18,500,000 6.600% | 7,300,000 (+65.18%) | Filing |